Publications by Dr Sarra Ryan - ePrints

Browsing publications by Dr Sarra Ryan.

Newcastle Authors	Title	Year
Claire Schwab Dr Ruth Cranston Dr Sarra Ryan Ellie Butler Emily Winterman et al.	Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial	2023
Dr Tom Creasey Emilio Barretta Dr Sarra Ryan Ellie Butler Dr Daniel Leongamornlert et al.	Genetic and genomic analysis of acute lymphoblastic leukaemia in older adults reveals a distinct profile of abnormalities: analysis of 210 patients from the UKALL14 and UKALL60+ clinical trials	2022
Claire Schwab Daniel Murdy Ellie Butler Dr Amir Enshaei Emily Winterman et al.	Genetic characterisation of childhood B-other-acute lymphoblastic leukaemia in UK patients by fluorescence in situ hybridisation and Multiplex Ligation-dependent Probe Amplification	2022
Dr Matthew Bashton Robin Hollis Dr Sarra Ryan Claire Schwab Professor Christine Harrison FRCPath FMedSci et al.	Concordance of copy number abnormality detection using SNP arrays and Multiplex Ligation-dependent Probe Amplification (MLPA) in acute lymphoblastic leukaemia	2020
Dr Paul Sinclair Dr Sarra Ryan Dr Matthew Bashton Shaun Hollern Rebecca Hanna et al.	SH2B3 inactivation through CN-LOH-12q is uniquely associated with B-cell precursor ALL with iAMP21 or other chromosome 21 gain	2019
Dr Paul Sinclair Dr Helen Blair Dr Sarra Ryan Dr Lars Buechler Joanna Cheng et al.	Dynamic clonal progression in xenografts of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21	2018
Dr Janet Lindsey Dr Rebecca Hill Dr Ed Schwalbe Dr Christopher Howell Dr Reza Rafiee et al.	Molecular and Prognostic Heterogeneity within MYC and MYCN Amplified Medulloblastomas	2016
Dr Sarra Ryan Elizabeth Matheson Dr Paul Sinclair Dr Matthew Bashton Claire Schwab et al.	The role of the RAS pathway in iAMP21-ALL	2016
Dr Paul Sinclair Joanna Cheng Prahlad Raninga Rebecca Hanna Shaun Hollern et al.	A Targeted Functional Clone Tracking Assay for the Identification of Tumour Suppressor Genes in BCP- ALL Implicates the Transcription Factors FOXO3 and PRDM1	2015
Dr Lisa Russell Lisa Jones Dr Amir Enshaei Jamie Rutherford Dr Stefano Tonin et al.	Clincial and Genetic Landscapes Differ Between IGH-CRLF2 and P2RY8-CRLF2 Acute Lymphoblastic Leukaemia	2015
Dr Lisa Russell Lisa Jones Dr Amir Enshaei Dr Stefano Tonin Dr Sarra Ryan et al.	Clincial and Genetic Landscapes Differ Between IGH-CRLF2 and P2RY8-CRLF2 Acute Lymphoblastic Leukaemia	2015
Claire Schwab Dr Sarra Ryan Professor Christine Harrison FRCPath FMedSci	Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia	2014
Claire Schwab Becca Andrews Dr Lucy Chilton Alannah Elliott Gerald Keil et al.	EBF1-PDGFRB Fusion in Paediatric Acute Lymphoblastic Leukaemia (ALL): Genetic Profile and Clinical Implications	2014
Dr Rebecca Hill Dr Janet Lindsey Dr Ed Schwalbe Dr Daniel Williamson Dr Sarra Ryan et al.	MYC and TP53 defects emerge and interact at medulloblastoma relapse, define rapidly progressive disease and can be targeted therapeutically	2014
Dr Rebecca Hill Dr Janet Lindsey Dr Ed Schwalbe Dr Karen Barker Dr Daniel Williamson et al.	MYC and TP53 defects interact at medulloblastoma relapse to define rapidly progressive disease and can be targeted therapeutically	2014
Jake Clayton Joanna Cheng Dr Sarra Ryan Professor Christine Harrison FRCPath FMedSci Dr Paul Sinclair et al.	Oncogenomic Screening Strategies to Identify Tumour Suppressor Genes on Chromosome 12 in Acute Myeloid Leukaemia	2014
Claire Schwab Becca Andrews Dr Lucy Chilton Alannah Elliott Dr Stacey Richardson et al.	SSBP2-CSF1R Is a Recurrent Fusion in B-Other Acute Lymphoblastic Leukaemia with Variable Clinical Outcome	2014
Dr Sarra Ryan Dr Ed Schwalbe Mike Cole Yuan Lu Dr Meryl Lusher et al.	MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastoma	2012
Professor David Ellison Dr Hisham Megahed Dr Meryl Lusher Dr Sarra Ryan Professor Simon Bailey et al.	Definition of Disease-Risk Stratification Groups in Childhood Medulloblastoma Using Combined Clinical, Pathologic, and Molecular Variables	2011
Dr Vikki Rand Dr Lisa Russell Claire Schwab Hannah Ensor Professor Julie Irving et al.	Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia	2011
Dr Ed Schwalbe Dr Janet Lindsey Debbie Straughton Mike Cole Dr Hisham Megahed et al.	Rapid Diagnosis of Medulloblastoma Molecular Subgroups	2011
Dr Sarra Ryan Dr Vikki Rand Claire Schwab Heather Morrison Elizabeth Matheson et al.	Ras Signalling Pathway and Novel Target Genes Related to Down Syndrome Contribute to the Development of B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) in iAMP21 Patients	2011
Dr Hisham Megahed Dr Sarra Ryan Dr Meryl Lusher Sarah Nicholson Professor Simon Bailey et al.	Clinical, Pathological, and Molecular Variables Define Risk-Stratification Groups in Childhood Medulloblastoma	2010
Professor David Ellison Dr Hisham Megahed Dr Sarra Ryan Dr Meryl Lusher Sarah Nicholson et al.	Clinical, pathological, and molecular variables define risk-stratification groups in childhood medulloblastoma	2010
Claire Schwab Lisa Jones Heather Morrison Dr Sarra Ryan Professor Christine Harrison FRCPath FMedSci et al.	Evaluation of Multiplex Ligation-Dependent Probe Amplification as a Method for the Detection of Copy Number Abnormalities in B-Cell Precursor Acute Lymphoblastic Leukemia	2010
Dr James Hayden Dr Matthew Allen Dr Sarra Ryan Sarah Nicholson Dr Ed Schwalbe et al.	Molecular Mechanisms in Supratentorial CNS-PNET development	2010
Professor Steven Clifford Dr Sarra Ryan Mike Cole Dr Meryl Lusher Kieran O'Toole et al.	MYC gene family amplification and expression in childhood medulloblastoma: Biological significance and utility for high-risk disease stratification	2010
Dr Sarra Ryan Professor David Elliott Professor David Ellison Professor Simon Bailey Professor Steven Clifford et al.	Amplification and overexpression of Hsa-miR-3ob, Hsa-miR-30d and KHDRBS3 at 8q24.22-q24.23 in medulloblastoma	2009